CD93 and neoplasm: More importantly, the overexpression of CD93 on tumor-associated blood vessels has been proven to be associated with advance tumor stage and poor prognosis in multiple cancer types, including lung squamous cell carcinoma (Tossetta et al. , 2023; Qu et al. 2024).